Paweł Sobczuk, MD PhD (he/him/his)

Medical Oncology Fellow
Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Poland

Medical Oncology Fellow at the Department of Soft Tissue/Bone Sarcoma and Melanoma in Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland. I am the ESMO Young Oncologists Committee, ESMO Communication Committee and CTOS Communication Committee member. Primarily interested in soft tissue sarcomas, including basic and translational research. Additionally, I am interested in the climate sustainability of cancer care and science communication.

Poster(s):

• (P 46) A NEED FOR STANDARDIZATION IN TRIAL DESIGN AND DATA REPORTING IN PHASE II TRIALS IN RARE TUMORS. LESSONS LEARNED FROM PHASE II TRIALS IN BONE SARCOMAS

• (P 245) PRELIMINARY RESULTS FROM A PHASE 2 EFTISARC-NEO TRIAL OF NEOADJUVANT SOUBLE LAG-3 PROTEIN EFTILAGIMOD ALPHA, PEMBROLIZUMAB, AND CONCURRENT RADIOTHERAPY IN PATIENTS WITH RESECTABLE SOFT TISSUE SARCOMA